Abstract
To measure the seasonal influenza vaccination coverage rate (VCR) in France in 2009, year of the A(H1N1) influenza pandemic, by age and target disease and compare it with the VCR for the 2007 and 2008 influenza seasons. At the beginning of each annual seasonal vaccination campaign, the National Health Insurance, covering 86% of the French population, sends free influenza vaccination vouchers to at-risk beneficiaries aged under 65 suffering from diverse chronic diseases and to all individuals aged 65 and over (around 11 million). Vaccination is estimated from refund claims registered in the National Health Insurance Information System. The global VCR for the target population was 51% in 2007, 55.8% in 2008 and 56.9% in 2009. In 2009, the VCR for children under 10 years old was 24.3%, 28.1% in the 10-19 age range, 39.2% in the 20-64 age range and 63.3% for individuals aged 65 and over, of which 72.3% with a targeted chronic disease and 56.9% without. The inclusion of asthma as a target disease, lowered the global VCR for children under 10 years old (30.6% without asthma) but VCR increased proportionally with the number of annual refunds for drugs against asthma and chronic obstructive pulmonary disease. The 2009 vaccine uptake ra...Continue Reading
References
Dec 7, 1994·JAMA : the Journal of the American Medical Association·T M GovaertJ A Knottnerus
Jan 29, 2000·The New England Journal of Medicine·H S IzurietaK Fukuda
Aug 13, 2004·BMC Public Health·Melissa K AndrewKenneth Rockwood
Sep 16, 2004·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Sep 20, 2005·Vaccine·Madelon KronemanW John Paget
Jun 29, 2006·Infection·R Jiménez-GarcíaA G de Miguel
Aug 22, 2006·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C Weil-OlivierM Maitre
Oct 13, 2006·BMC Public Health·Punam MangtaniAstrid Fletcher
Jun 5, 2007·Vaccine·Noelle-Angelique M MolinariCarolyn B Bridges
Sep 11, 2007·Vaccine·Yue ChenFelix Li
Jan 15, 2008·Médecine et maladies infectieuses·B LinaT D Szucs
Aug 30, 2008·Vaccine·Marlène Murris-EspinJean-Christophe Dubus
Oct 18, 2008·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·J MereckieneUNKNOWN VENICE Gatekeepers Group
Oct 25, 2008·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A NicollC Yilmaz
Oct 25, 2008·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·M ValencianoUNKNOWN Influenza Vaccine Effectiveness Working Group
Oct 25, 2008·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·F RanceC Weil-Olivier
Oct 25, 2008·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·J MereckieneUNKNOWN VENICE Project Gatekeepers Group
Feb 21, 2009·Vaccine·Kristin L Nichol
May 19, 2009·The Journal of Infection·Patricia R BlankThomas D Szucs
Sep 22, 2009·Infection·P R BlankT D Szucs
Oct 3, 2009·Médecine et maladies infectieuses·P TuppinH Allemand
Oct 21, 2009·Vaccine·Kristin L Nichol
Mar 23, 2010·Preventive Medicine·Keri N AlthoffStephen J Gange
Mar 27, 2010·BMC Public Health·Sophie VauxDaniel Lévy-Bruhl
Apr 28, 2010·PloS One·Michaël SchwarzingerJean-Paul Moatti
May 25, 2010·Vaccine·Liisa A PalmerKristin L Nichol
Jul 24, 2010·Vaccine·Cristina Rodríguez-RieiroRodrigo Jiménez-García
Sep 9, 2010·Médecine et maladies infectieuses·M Mohseni-ZadehM Martinot
Citations
Oct 12, 2014·Blood·Guillaume MoulisLaurent Sailler
Nov 16, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A L Caille-BrilletM Setbon
Mar 22, 2013·BMC Public Health·Ludivine PrivileggioSolen Kernéis
May 19, 2012·Italian Journal of Pediatrics·Giuseppe GregoriRoberto Sacchetti
Mar 12, 2013·La Revue de médecine interne·E RouveixUNKNOWN Intergroupe Société de pathologie infectieuse de langue française/Société de gériatrie et gérontologie clinique (Spilf/SGGC)
Jul 17, 2012·La Presse médicale·Philippe TuppinHubert Allemand
Sep 1, 2015·Vaccine·Karine BoironThierry Blanchon
Jun 30, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P VergerO Launay
Jan 6, 2015·American Journal of Hematology·Guillaume MoulisLaurent Sailler
Dec 31, 2014·La Revue de médecine interne·G MoulisL Sailler
Jun 3, 2014·BMC Family Practice·Louise MaherStephen Conaty
Jul 3, 2013·Human Vaccines & Immunotherapeutics·Alessandra FalchiThierry Blanchon
Apr 10, 2012·Human Vaccines & Immunotherapeutics·Juana María Santos-SanchoRodrigo Jiménez-García
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Catherine Weil Olivier
Jul 5, 2012·Preventive Medicine·Iván Martínez-BazJesús Castilla
Apr 30, 2016·Pharmacoepidemiology and Drug Safety·Line SahliGuillaume Moulis
Apr 28, 2010·PloS One·Michaël SchwarzingerJean-Paul Moatti
Sep 17, 2013·PloS One·Marion DebinVittoria Colizza
Mar 11, 2011·La Presse médicale·Philippe TuppinHubert Allemand
Sep 15, 2016·Human Vaccines & Immunotherapeutics·Yu HuBing Zhang
Apr 27, 2017·Influenza and Other Respiratory Viruses·Ting F LeungPaul K S Chan
Nov 7, 2017·Allergy·J SchwarzeC Skevaki
Jan 23, 2015·BMC Health Services Research·Candace LindAmy E Davis
Sep 4, 2012·Current Infectious Disease Reports·Catherine J Derber, Shivanjali Shankaran
Jul 31, 2013·PloS One·Adeline BernierLaurence Watier
Dec 13, 2016·Applied Health Economics and Health Policy·L GerlierM Eichner
Jan 20, 2019·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A-G MarienF Dubos
Dec 31, 2019·La Revue de médecine interne·G PugnetL Sailler